Atlas Trials

Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients

Clinical trial NCT07211659 · RECRUITING

Trial details

NCT number
NCT07211659
Sponsor
Theolytics Limited
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2026-02-13
Primary completion
2027-09-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.